Results 21 to 30 of about 429,593 (156)
Pifu-xingbing zhenliaoxue zazhi, 2020 Objective: To investigate the clinical significance of interleukin-33(IL-33) and soluble ST2 (sST2) in patients with vitiligo. Methods: The serum concentrations of IL-33 and sST2 were determined by enzyme linked immunosorbent assay (ELISA) respectively ...
Li YANG, Dong-qing LU, Han MA
doaj +1 more source
IL-31 and IL-33 in rheumatoid arthritis patients
Научно-практическая ревматология, 2022 Objective – to investigate clinical and diagnostic significance of IL-31 and IL-33 determination in patients with rheumatoid arthritis (RA).Material and methods. 154 patients with a reliable diagnosis of RA were examined.
N. A. Lapkina +8 more
doaj +1 more source
Effects of IL-33 on HaCAT cell line and psoriasis-like lesion in mouse model [PDF]
Jichu yixue yu linchuang, 2020 Objective To investigate the effects of interleukin-33(IL-33)on HaCAT cells and psoriasis-like inflammation induced by imiquimod(IMQ) in mice. Methods Twenty-four hours after HaCAT cells were plated, the cell proliferation and autophagy-related protein ...
DUAN Ya-ju, WANG Wen-qian, HU Hua, FU Dan-dan, SONG Xiang-feng, TIAN Zhong-wei
doaj
Understanding Interleukin 33 and Its Roles in Eosinophil Development
Frontiers in Medicine, 2017 Over the last decade, significant interest in the contribution of three “epithelial-derived cytokines,” such as thymic stromal lymphopoietin, interleukin 25, and interleukin 33 (IL-33), has developed.
Paul J. Bryce, Laura K. Johnston
doaj +1 more source
Journal of Medicine in Scientific Research, 2020 Aim The aim was to study the role of interleukin (IL)-33 in rheumatoid arthritis (RA)-induced generalized bone loss in premenopausal women and its relation to general disease activity and various laboratory markers.
Taghreed F M. Mostafa +3 more
doaj +1 more source
Biomedicines, 2021 The markers of the tumor microenvironment (TME) are promising prognostic and predictive factors in oral squamous cell carcinoma (OSCC). The current study aims to analyze the immunohistochemical expression of programmed cell death-ligand 1 (PD-L1) and ...
Łukasz Jan Adamski +9 more
doaj +1 more source
Interleukin-33 Potentiates Bleomycin-Induced Lung Injury [PDF]
American Journal of Respiratory Cell and Molecular Biology, 2013 The mechanisms of interstitial lung disease (ILD) remain incompletely understood, although recent observations have suggested an important contribution by IL-33. Substantial elevations in IL-33 expression were found in the lungs of patients with idiopathic pulmonary fibrosis and scleroderma lung disease, as well as in the bleomycin injury mouse model ...
Irina G, Luzina +8 more
openaire +2 more sources
Journal of Translational Medicine, 2020 Background Interleukin-33 (IL-33) is an effective inducer of pro-inflammatory cytokines regulating innate and adaptive immunity. Inflammation could be a double-edged sword, promoting or inhibiting tumour growth. To date, the roles and mechanisms of IL-33
Wenxiu Wang +3 more
doaj +1 more source
The Role of Interleukin-33 in Rhinitis [PDF]
Current Allergy and Asthma Reports, 2013 IL-33, a member of the IL-1 cytokine family and a ligand to receptor ST2, has great potential to induce a T helper 2-type inflammatory response. IL-33 is proven to be released by epithelial cells during their injury by different environmental stimuli such as airborne allergens, viruses, and air pollutants. IL-33 acting as an endogenous danger signal is
Rogala, Barbara, Glück, Joanna
openaire +2 more sources
Role of interleukins in heart failure with reduced ejection fraction
Anatolian Journal of Cardiology, 2019 Heart failure (HF) is the leading cause of morbidity and mortality in developed countries, and it is the primary cause of mortality in the elderly worldwide.
Oliwia Anna Segiet +4 more
doaj +1 more source